Which imaging modality provides information about myocardial viability and fibrosis in heart failure?

• A. Cardiac MRI can assess viability and fibrosis
• B. Echocardiography is sufficient
• C. CT angiography is the only modality
• D. Nuclear imaging is the only tool

Answer: (A)

Understanding myocardial tissue health is essential in heart failure care because knowing which areas of the heart muscle are still alive and which are scarred helps guide therapy. Cardiac MRI stands out because it directly characterizes tissue.

With late gadolinium enhancement, cardiac MRI highlights fibrotic or scarred tissue. Gadolinium tends to accumulate in areas with expanded extracellular space, so scarred regions appear brighter on the images. This lets you see not only where fibrosis is, but also how extensive it is and whether the scar spans the full wall thickness (transmural) or is more limited. Transmural extent is useful for predicting whether a region is likely to recover function after interventions like revascularization.

Beyond scar visualization, MRI can assess viability by combining tissue characterization with functional imaging. Cine MRI shows how well different parts of the heart pump, and combining this with the scar map helps determine if a dysfunctional region has viable, contractile myocardium that could improve with treatment. Advanced MRI techniques, like T1 mapping and extracellular volume assessment, can quantify diffuse fibrosis that might not be obvious on standard imaging.

While echocardiography excels at measuring structure and function, it does not provide the same direct, detailed information about fibrosis and tissue viability. Nuclear imaging can indicate viability through perfusion and metabolic studies but doesn’t characterize fibrosis as directly or comprehensively as MRI. CT can show scar with contrast in some protocols but is less routinely used for detailed tissue characterization and carries more radiation exposure.

So, cardiac MRI provides comprehensive information about both myocardial viability and fibrosis in a single, versatile modality.